Acadia Pharmaceuticals, Inc. (ACAD) announced that DAYBUE (trofinetide), a treatment for Rett syndrome, has been approved by the US FDA for use in adults and children over the age of two. The first and only drug that has been approved for the treatment of Rett syndrome is DAYBUE. This day marks a significant turning point […]
Continue Reading
The Centers for Disease Control and Prevention (CDC) in the United States will stop requiring travellers from China to take COVID-19 tests, joining other nations that have done so. This information comes from a reliable source. Last week, Japan stopped requiring all Chinese arrivals to take a virus test. The United States would keep an […]
Continue Reading
The US Food and Drug Administration (FDA) has approved Amphastar Pharmaceuticals, Inc.’s New Drug Application (NDA) for naloxone hydrochloride nasal spray, 4 milligrams, to treat Opioid Overdose. Naloxone hydrochloride nasal spray 4mg is indicated for the immediate treatment of adult and pediatric patients suffering from respiratory and/or central nervous system depression as a result of […]
Continue Reading
India logged 379 new COVID-19 contaminations, while the dynamic cases rose to 3,177, as per the Association Wellbeing Service information refreshed. India’s Maharashtra state has reported one death out of 5,30,776 reported victims, according to data updated at 8 a.m. The number of COVID-19 cases was 4.46 crore (4,46,89,072). The ministry’s website states that the […]
Continue Reading
Alembic Pharmaceuticals Ltd announced that, Brexpiprazole tablets, which are used to treat schizophrenia and major depressive disorder, have received tentative approval from the United States Food and Drug Administration (FDA). Abbreviated New Drug Application (ANDA) Brexpiprazole Tablets in strengths of 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg have received […]
Continue Reading
Nelarabine Injection, an oncology drug developed by Shorla Oncology, has received US FDA approval for the treatment of T-cell Acute Lymphoblastic Leukemia (T-ALL) and T-cell Lymphoblastic Lymphoma (T-LBL). Nelarabine Injection offers patients a substitute for a product that has historically been scarce. Sharon Cunningham, CEO and co-founder of Shorla Oncology, said that they are very […]
Continue Reading
The most popular insulins manufactured by Eli Lilly will have seen significant price reductions. Eli Lilly, a pharmaceutical company, has announced plans to reduce the price of its Humalog and Humulin insulins by 70%. This price cut was made public after the price of insulin skyrocketed, which was heavily criticized by lawmakers in the United […]
Continue Reading
The US FDA approved Alaembic Pharma’s Fluorouracil Injection USP, 2.5 g/50 mL (50 mg/mL) in India. Patients with colon and rectal adenocarcinomas, breast adenocarcinomas, gastric adenocarcinomas, and pancreatic adenocarcinomas are treated with the injection. Fluorouracil Infusion has an expected market size of $5 million for a considerable length of time finishing December 2022, as indicated […]
Continue Reading
Zydus Lifesciences’ Acyclovir Cream, 5%, which is used to treat cold sores on the face and lips, received final approval from the United States Food and Drug Administration (FDA). Blisters known as cold sores are brought on by the herpes simplex virus. Acyclovir is a member of the antiviral class of drugs. The product will […]
Continue Reading
AstraZeneca India made its entry into the treatment of rare diseases in India on Tuesday. The company’s ‘Selumetinib’ for Indian patients has been approved by regulators. Regarding rare diseases, there is neither a precise estimation of the rate of mortality or morbidity in India nor an understanding of the disease burden on the public healthcare […]
Continue Reading